Want access to these reports and real time alerts? Go to www.tradethetrend.com now for a FREE two-week trial.

Write to Chip Brian at cbrian@tradethetrend.com

---------------------------------------------------------------------------------------------

SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html

Go to www.mysmartrend.com now for a FREE two-week trial.

Write to Chip Brian at cbrian@tradethetrend.com

---------------------------------------------------------------------------------------------

SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html

The ValuEngine Rating is an overall assessment of a stock's attractiveness. It combines the following five factors: ValuEngine's proprietary valuation, risk-return tradeoff, momentum, market capitalization and ValuEngine's proprietary forecasted one-month return. Approximately 80 to 85 companies achieve this highest ValuEngine rating out of VE's total coverage of over 5,000 publicly traded companies.

ValuEngine is a subscription-based business intelligence, market and equity analysis firm that provides exclusive, customized research and analysis solutions directly to companies, investors, investment banks and broker-dealers. A special arrangement between the Investrend Research Syndicate and ValuEngine provides for preferred introductions and complimentary value-added services for those enrolling into ValuEngine programs. For more information write to valuengine@investrend.com. To receive ValuEngine research and commentary news alerts, write to firstalert@investrend.com with "ValuEngine" in the subject line.

The Investrend Research Syndicate, a proprietary entity of Investrend Communications, Inc., distributes equity research-related information issued by sources that deemed to be dedicated to unbiased, reliable and transparent analytics. The primary measure for vetting those sources is the "Standards for Independent Research Providers" as promulgated by the FIRST Research Consortium.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

http://www.financialwire.net

Tenet Hospitals Awarded 257 CIGNA HealthCare Quality Designations

DALLAS-- Tenet Healthcare Corporation (NYSE: THC) today announced that 42 of its hospitals received 257 quality designations through CIGNA HealthCare.

These quality designations are based on outcomes for treatment of 29 surgical procedures and medical conditions. The patient outcomes data are based partially on a hospital's Centers for Medicare and Medicaid Services (CMS) Hospital Compare measures, Leapfrog Patient Safety Measures, mortality and complications rates. The designations indicate superior outcomes and nearly 65 percent of CIGNA HealthCare's network hospitals receive a quality designation for treatment of at least one condition.

Monsterstox.com offers daily newsletter on potentially huge movers in the market. These include stocks with momentum and abnormal volume. We also profile undervalued stocks, penny stocks, stocks with positive technical indicators and much more. Our team of experienced Traders search the market for stocks that are overlooked by the crowd.

We encourage investors to join to our FREE newsletter by visiting: http://www.Monsterstox.com

ABOUT MONSTERSTOX.COM

Monsterstox.com is a leading stock website that provides FREE newsletters on stocks that are potential huge movers. Monsterstox.com also tracks micro cap stocks that could be undervalued by the market. Monsterstox.com strives to provide an edge to Traders and Investors with its FREE newsletter service.

Monsterstox.com is an independent electronic publication that provides information on selected publicly traded companies. Monsterstox.com is not a registered investment advisor or broker-dealer. Monsterstox.com affiliates, officers, directors and employees may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.

CONTACT: Monsterstox.com e-mail: info@monsterstox.com

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.